Top 10 Companies in the (R)-1-(3-Fluorophenyl)-1-Propanol Market (2026): Market Leaders Powering Global Pharmaceutical Innovation

MARKET INSIGHTS

Global (R)-1-(3-Fluorophenyl)-1-propanol market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a CAGR of 6.4% during the forecast period.

(R)-1-(3-Fluorophenyl)-1-propanol is a chiral secondary alcohol bearing a fluorine substituent at the meta position of the phenyl ring, with the molecular formula C₉H₁₁FO. As an optically active compound, it is widely utilized as a key chiral building block and intermediate in the synthesis of pharmaceutical active ingredients, agrochemicals, and fine chemicals. Its defined stereochemistry makes it particularly valuable in asymmetric synthesis and enantioselective catalysis applications.

The market is witnessing steady growth, driven primarily by rising demand for enantiomerically pure intermediates in drug discovery and pharmaceutical manufacturing. Furthermore, increasing adoption of chiral synthesis technologies and expanding contract research and manufacturing organizations (CROs and CMOs) globally are reinforcing market expansion. Key suppliers operating in this space include Sigma‑Aldrich (Merck KGaA), TCI Chemicals, and Alfa Aesar, among other specialty fine chemical manufacturers maintaining focused portfolios of fluorinated chiral alcohols.

(R)-1-(3-Fluorophenyl)-1-propanol Market – View in Detailed Research Report

Top 10 Companies in the (R)-1-(3-Fluorophenyl)-1-Propanol Market (2026)

10️⃣ 1. Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany
Key Offering: High‑purity (R)-1-(3‑Fluorophenyl)-1‑propanol and custom synthesis services

Sigma‑Aldrich continues to set the benchmark for chiral intermediates, leveraging an integrated R&D and manufacturing footprint that spans Europe, Asia, and the Americas. The firm’s commitment to precision chemistry ensures consistent enantiomeric excess above 99.5 %, supporting the development of next‑generation CNS and anti‑inflammatory agents.

Sustainability Initiatives:

• Investment in green chemistry platforms and renewable feedstocks
• Reduction of solvent usage through continuous‑flow technologies
• Compliance with ISO 14001 and ISO 9001 standards across all sites

• GMP‑certified production
• Enantiomeric purity >99.5 % ee
• Global distribution network

9️⃣ 2. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: Commercial supply of (R)-1-(3‑Fluorophenyl)-1‑propanol and technical support

TCI Chemicals is renowned for its high‑quality fine chemicals and has established a strong presence in the chiral market through rigorous quality control and rapid delivery capabilities.

Sustainability Initiatives:

• Waste minimization and recycling programs
• Energy‑efficient manufacturing processes
• Adherence to Japan’s stringent environmental regulations

• ISO 9001 certification
• High enantiomeric purity >99.5 % ee
• Extensive technical support for API development

8️⃣ 3. Alfa Aesar

Headquarters: Haverhill, USA
Key Offering: Research‑grade (R)-1-(3‑Fluorophenyl)-1‑propanol for academic and small‑scale industrial use

Alfa Aesar caters to the research community with a broad portfolio of chiral reagents, facilitating early‑stage discovery and method development.

Sustainability Initiatives:

• Eco‑friendly packaging options
• Support for open‑science collaborations
• Commitment to reducing hazardous waste

• ISO 9001 and ISO 14001 certifications
• Enantiomeric purity >99.5 % ee
• Rapid turnaround for small‑batch orders

7️⃣ 4. Hairui Fine Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Large‑scale production of (R)-1-(3‑Fluorophenyl)-1‑propanol at competitive pricing

Hairui Fine Chemical has expanded its production capacity to meet the growing demand from Asian pharmaceutical manufacturers, focusing on cost efficiency without compromising quality.

Sustainability Initiatives:

• Compliance with China’s environmental standards
• Use of recycled solvents and energy‑saving equipment
• Investment in local renewable energy projects

• GMP‑certified facilities
• Enantiomeric purity >99.5 % ee
• Robust supply chain for regional clients

6️⃣ 5. Finetech Industry Limited

Headquarters: Shenzhen, China
Key Offering: Custom synthesis and high‑purity intermediates tailored to client specifications

Finetech Industry has positioned itself as an agile partner for both emerging biotech firms and established manufacturers, leveraging close collaboration with local research institutions.

Sustainability Initiatives:

• Biocatalytic processes to reduce chemical waste
• Partnerships with universities for green chemistry research
• Carbon‑neutral production targets

• ISO 9001 certification
• Enantiomeric purity >99.5 % ee
• Flexible production schedules for custom orders

5️⃣ 6. Shanghai Trustin Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Specialty fluorinated intermediates, including (R)-1-(3‑Fluorophenyl)-1‑propanol

Shanghai Trustin has built a reputation for delivering high‑quality fluorinated chemicals with stringent quality control protocols.

Sustainability Initiatives:

• Zero‑hazard waste management
• Energy‑efficient plant operations
• Compliance with national safety regulations

• ISO 9001 and ISO 14001 certifications
• Enantiomeric purity >99.5 % ee
• Dedicated technical support team

4️⃣ 7. Beijing Mesochem Technology Co., Ltd.

Headquarters: Beijing, China
Key Offering: Advanced asymmetric synthesis and high‑purity chiral intermediates

Beijing Mesochem invests heavily in AI‑driven catalyst design, enabling rapid optimization of reaction conditions and higher yields.

Sustainability Initiatives:

• Carbon footprint reduction through process optimization
• Use of renewable energy sources in production
• Participation in national green chemistry programs

• GMP‑certified facilities
• Enantiomeric purity >99.5 % ee
• High‑throughput synthesis capabilities

3️⃣ 8. Apollo Scientific Ltd.

Headquarters: London, United Kingdom
Key Offering: High‑purity intermediates with full regulatory compliance for the EU market

Apollo Scientific serves pharmaceutical companies across Europe, ensuring strict adherence to EMA and REACH requirements while delivering superior stereochemical quality.

Sustainability Initiatives:

• Compliance with REACH and RoHS directives
• Energy‑efficient manufacturing processes
• Use of recyclable materials in packaging

• ISO 9001 and ISO 14001 certifications
• Enantiomeric purity >99.5 % ee
• Dedicated regulatory affairs team

2️⃣ 9. Oakwood Products, Inc.

Headquarters: Cleveland, USA
Key Offering: Custom synthesis and GMP‑grade (R)-1-(3‑Fluorophenyl)-1‑propanol for the North American market

Oakwood Products focuses on delivering tailored solutions to pharmaceutical developers, emphasizing rapid scale‑up and stringent quality control.

Sustainability Initiatives:

• Green chemistry programs to reduce solvent use
• Waste‑to‑energy conversion for by‑products
• Participation in industry sustainability consortiums

• GMP certification
• Enantiomeric purity >99.5 % ee
• Integrated logistics for fast delivery

1️⃣ 10. Fluorochem Ltd.

Headquarters: Cambridge, United Kingdom
Key Offering: Specialty fluorinated chemicals, including (R)-1-(3‑Fluorophenyl)-1‑propanol for niche applications

Fluorochem specializes in high‑purity fluorinated intermediates, catering to both pharmaceutical and agrochemical sectors with a focus on precision and reliability.

Sustainability Initiatives:

• Eco‑friendly synthesis routes with minimal hazardous waste
• Use of renewable feedstocks where possible
• Commitment to ISO 14001 environmental management

• ISO 9001 and ISO 14001 certifications
• Enantiomeric purity >99.5 % ee
• Custom order fulfillment and technical support

Download FREE Sample Report

Get Full Report

Market Outlook

The trajectory of the (R)-1-(3-Fluorophenyl)-1-propanol market is shaped by the escalating need for enantiomerically pure intermediates in modern drug development. As pharmaceutical companies refine their pipelines toward precision medicine, the demand for high‑purity chiral building blocks is set to rise. Concurrently, advancements in biocatalytic and continuous‑flow synthesis are lowering production costs, expanding the commercial viability of this niche intermediate across multiple therapeutic areas.

Emerging Trends

• Adoption of AI‑driven catalyst design to accelerate reaction optimization
• Growth of contract manufacturing organizations specializing in chiral synthesis, offering end‑to‑end solutions
• Increased regulatory focus on chiral purity, prompting stricter quality controls and faster approval pathways
• Expansion into agrochemical and material science applications, diversifying the end‑user base
• Implementation of green chemistry initiatives, such as solvent‑free reactions and renewable feedstocks, to meet ESG objectives